Mahal A S, Knauer C M, Gregory P B
West J Med. 1981 Jan;134(1):11-4.
During nine years 3,080 liver biopsies were carried out and bleeding occurred in 22 of the patients (0.7 percent). Transfusions were given to 17 of these patients and laparotomies were done to control the bleeding in six. All survived. Bleeding was evident within three hours in 19 patients, but occurred from 3 to 13 days after biopsy in the remaining three. Pain requiring analgesic medication and a fall in blood pressure were the usual indications that major bleeding had occurred. Relative contraindications to biopsy (particularly a prolonged prothrombin time) were present in 10 of the 22 bleeding patients and in only 2 of the 41 nonbleeding controls (P<0.001). We believe that some of the bleeding episodes could have been prevented with more careful attention to the indications and contraindications to biopsy, and more rigorous correction of recognized clotting abnormalities.
在九年时间里,共进行了3080例肝活检,其中22例患者(0.7%)出现出血。这些患者中有17例接受了输血治疗,6例进行了剖腹手术以控制出血。所有患者均存活。19例患者在三小时内出现明显出血,但其余三例在活检后3至13天出现出血。需要止痛药物治疗的疼痛和血压下降是大出血发生的常见指征。22例出血患者中有10例存在活检的相对禁忌证(尤其是凝血酶原时间延长),而41例未出血的对照患者中只有2例存在相对禁忌证(P<0.001)。我们认为,通过更仔细地关注活检的适应证和禁忌证,以及更严格地纠正已识别的凝血异常,部分出血事件本可避免。